Since 1993, 15 disease-modifying therapies have been approved by the FDA for the treatment of relapsing-remitting multiple sclerosis ... products and glatiramer acetate. Although more recently ...

Glatiramer acetate (GA) for relapsing–remitting multiple sclerosis (MS) is currently FDA-approved at a 20 mg/day dose. Efficacy and safety comparisons with other doses have not yet been reported.

For patients suffering from multiple sclerosis (MS), becoming ... A study on the drug glatiramer acetate can relieve mothers of this concern during the breastfeeding period. A comparative study ...

BG-12 (dimethyl fumarate) is in development as an oral treatment for relapsing–remitting multiple sclerosis, which is commonly treated with parenteral agents (interferon or glatiramer acetate).

Germany), was presented today at EAN congress and provided new insight on the use of COPAXONE® (glatiramer acetate or GA) by mothers with multiple sclerosis (MS) who are breastfeeding.

There were 35,312 MS patients with 12 months of follow-up including 12,144 (34.4%) patients on GA therapy; 21,927 patients were identified with 24 months of follow-up, including 7,386 (33.7%) on ...

Patients with relapsing-remitting multiple sclerosis are typically treated with parenterally administered interferon or glatiramer acetate. BG-12 (dimethyl fumarate) is an orally available agent ...

Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction, linked to certain multiple sclerosis (MS) drugs, including glatiramer acetate ...

This international Phase III trial in patients with relapsing-remitting multiple sclerosis (RRMS), is ... tolerability of 40mg COPAXONE ® (glatiramer acetate injection) administered three times ...

1.4 Interferon beta‑1b (Betaferon) is not recommended within its marketing authorisation as an option for treating multiple sclerosis. 1.5 These recommendations are not intended to affect treatment ...

Oct. 8 -- TUESDAY, Oct. 6 (HealthDay News) -- Among patients who show early signs of multiple sclerosis, treatment with a drug called glatiramer acetate appears to halve the risk that they will ...

More information: Andrea Ines Ciplea et al, Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis—COBRA study ...